Ashwagandha (<i>Withania somnifera (L.) Dunal</i>) for promoting recovery in long covid: protocol for a randomised placebo-controlled clinical trial (APRIL Trial).
第一单位:
Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK poppy.mallinson1@lshtm.ac.uk.
作者:
医学主题词
成年人(Adult);女(雌)性(Female);人类(Humans);男(雄)性(Male);双盲法(Double-Blind Method);植物药疗法(Phytotherapy);植物提取物(Plant Extracts);生活质量(Quality of Life);随机对照试验(主题)(Randomized Controlled Trials as Topic);治疗结果(Treatment Outcome);睡茄属(Withania);醉茄内酯类(Withanolides)
DOI
10.1136/bmjopen-2024-094526
PMID
40280611
发布时间
2025-06-05
- 浏览1
BMJ open
e094526页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



